GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety, bleeding pattern of low dose LNG
(12 mg/ 24 hrs), delivered locally by a new intrauterine contraceptive system suitable for
use by women 18 to 40 years of age. In addition, pharmacokinetic assessments will be
performed.